N-Phenyl-Pyrazolo[1,5-A]pyridine Derivatives Treat Urticaria
Summary
The European Patent Office has published patent application EP4626884A1 concerning N-Phenyl-Pyrazolo[1,5-A]pyridine derivatives as inhibitors for treating urticaria. The application lists Blueprint Medicines Corporation as the applicant.
What changed
The European Patent Office has published patent application EP4626884A1, detailing N-Phenyl-Pyrazolo[1,5-A]pyridine derivatives developed by Blueprint Medicines Corporation. These compounds are identified as wild type c-Kit kinase inhibitors intended for the treatment of urticaria and other related conditions, as indicated by the IPC classifications.
This publication represents a new patent filing and does not impose immediate compliance obligations on regulated entities. However, it is relevant for pharmaceutical companies and drug manufacturers monitoring intellectual property and therapeutic developments in the field of immunology and dermatology. Compliance officers in the pharmaceutical sector should note this filing for competitive intelligence and potential future licensing or research considerations.
Source document (simplified)
N-PHENYL-PYRAZOLO[1,5-A]PYRIDINE-3-CARBOXAMIDE DERIVATIVES AS WILD TYPE C-KIT KINASE INHIBITORS FOR THE TREATMENT OF URTICARIA
Publication EP4626884A1 Kind: A1 Mar 11, 2026
Applicants
Blueprint Medicines Corporation
Inventors
BRUBAKER, Jason, D., DAI, Yinghui, DINEEN, Thomas, A., DU, Guangyan, FANG, Cheng, HAIDLE, Andrew, Marc, KIM, Joseph, L., PEROLA, Emanuele, SAMARAKOON, Thiwanka, WILSON, Douglas
IPC Classifications
C07D 471/04 20060101AFI20240607BHEP A61K 31/437 20060101ALI20240607BHEP A61P 3/10 20060101ALI20240607BHEP A61P 9/12 20060101ALI20240607BHEP A61P 11/00 20060101ALI20240607BHEP A61P 11/06 20060101ALI20240607BHEP A61P 17/00 20060101ALI20240607BHEP A61P 17/06 20060101ALI20240607BHEP A61P 25/00 20060101ALI20240607BHEP A61P 25/28 20060101ALI20240607BHEP A61P 29/00 20060101ALI20240607BHEP A61P 35/00 20060101ALI20240607BHEP A61P 35/02 20060101ALI20240607BHEP A61P 37/00 20060101ALI20240607BHEP A61P 37/02 20060101ALI20240607BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Organic Chemistry (C07D) publishes new changes.